How to Get Tirzepatide Prescribed Online in New York

New York residents have exactly two legitimate ways to get tirzepatide online: a prescription for the FDA-approved brand-name product (Zepbound® or Mounjaro®, both made by Eli Lilly) or a compounded preparation from a US-licensed compounding pharmacy under FDCA §503A — and both require a New York-licensed clinician to review your health history first. Everything else — a site that ships tirzepatide with no prescription, or labels it "research use only" — isn't a cheaper third option. It's outside the law. See our New York state page for current availability, or read on for exactly how the legitimate process works for New York residents.

How do I get tirzepatide prescribed online in New York?

The process is the same two-step structure used for any GLP-1 in New York, applied to tirzepatide specifically:

1. You complete an online intake. Medical history, current medications, prior GLP-1 or tirzepatide use, and your goals — typically 5–10 minutes.
2. A New York-licensed clinician reviews it, usually asynchronously by secure message. New York doesn't require a video visit by state rule for non-controlled medications like tirzepatide, so most patients never schedule one — though a clinician may ask for a brief video visit or additional labs if your history calls for it.
3. The clinician decides whether tirzepatide is appropriate, and if so, which form — brand-name or compounded — fits your situation. This is a clinical decision, not a guarantee tied to submitting a form.
4. A licensed pharmacy fills the prescription and ships it to your New York address, typically within 2–3 business days of the pharmacy filling the order — patients in New York City and Long Island typically receive medication fastest, and upstate or rural ZIP codes may take an extra day.

That process doesn't change based on where in New York you live — whether you're in New York City, Long Island, Buffalo, Rochester, Syracuse, or Albany, the intake, the clinician review, and the price are the same. For the fuller national walkthrough of each step, including what disqualifies someone, see how to get tirzepatide online; this piece focuses on what's specific to New York.

Who can prescribe tirzepatide to a New York resident?

New York requires any clinician prescribing to a New York resident to hold an active New York medical license — a license from another state isn't enough, even for an otherwise identical telehealth visit. That authority isn't limited to physicians: under the Nurse Practitioner Modernization Act (N.Y. Educ. Law §6902), a nurse practitioner with more than 3,600 hours of practice experience can prescribe independently, with no physician agreement required; newer NPs prescribe under a written collaborative agreement with a physician. Tirzepatide is not a controlled substance, so New York permits the entire process — intake, prescription, and follow-up — through telehealth, as long as the treating clinician holds active New York licensure or prescriptive authority.

Zepbound® vs. Mounjaro®: which one gets prescribed?

Zepbound® and Mounjaro® are the same molecule, tirzepatide, made by the same manufacturer, Eli Lilly — but they carry different FDA-approved indications. Zepbound® is approved for chronic weight management; Mounjaro® is approved for type 2 diabetes. Which one a New York-licensed clinician prescribes depends on your diagnosis, not on which is easier to find. Brand-name tirzepatide dispensed through Pallas is cash-pay only and is not billed to insurance.

Is compounded tirzepatide legitimate in New York?

It can be — legitimacy depends on the pharmacy and the clinician behind it, not on the fact that it's compounded. A US-licensed compounding pharmacy operating under §503A is a real, regulated source, and New York residents are eligible for compounded tirzepatide when a New York-licensed clinician documents a patient-specific clinical rationale. What makes a compounded tirzepatide prescription legitimate in New York, specifically:

• A named, licensed pharmacy. A legitimate provider can tell you exactly which US-licensed pharmacy prepares your medication.
• A New York-licensed clinician's documented rationale. Both the tirzepatide shortage (resolved December 19, 2024) and the semaglutide shortage (resolved February 21, 2025) have ended, so shortage status no longer justifies a compounded prescription anywhere, including New York. Under §503A(b)(1)(C), your clinician compounds only when they document a patient-specific clinical reason an FDA-approved product isn't appropriate for you — not for price or preference alone.
• A real clinician review, the same standard as any brand-name prescription.

Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.

Does New York Medicaid cover tirzepatide?

It's not automatic, and it depends on the indication. New York Medicaid's GLP-1 coverage is broader than some states — it can extend to weight-management indications, not just diabetes — but coverage is typically subject to step therapy and prior authorization, and compounded tirzepatide is not covered under any circumstance. Pallas is a cash-pay telehealth service — no insurance is billed for either tier — so this doesn't change how the intake or pricing works with us, but it's worth knowing if you were assuming Medicaid coverage applied. For current pricing, see what tirzepatide costs and the New York cost page.

What makes an online tirzepatide seller illegitimate?

The pattern is consistent whether the site is selling "generic Zepbound," "research tirzepatide," or something with a made-up brand name entirely:

• No prescription required. Tirzepatide is a prescription medication everywhere in the US, including New York. Any seller willing to ship it without a clinician's review is operating illegally.
• "Research use only" or "not for human use" labeling. This signals the product isn't intended, tested, or regulated as a medicine — it isn't a legal workaround for selling it as one.
• The seller won't name its pharmacy. A legitimate telehealth provider can tell you exactly which licensed pharmacy — retail or a named compounding pharmacy — is filling your order.
• No verifiable certification. LegitScript maintains a public database of certified healthcare merchants. Check any provider — including Pallas — before paying, and confirm the certification is current.
• Prices that don't add up. A price far below what named, licensed providers charge, from a source that won't say where the drug comes from, is a counterfeit or unregulated-sourcing risk, not a bargain.

Two free lookups cover most of the verification: LegitScript's certification database for the provider, and the FDA's BeSafeRx locator to confirm the pharmacy itself is state-licensed. You can also check any New York-licensed clinician directly through the New York State Education Department's license lookup.

The bottom line

New York residents can get tirzepatide prescribed online through a real clinical process: an intake questionnaire, review by a New York-licensed clinician (physician or NP), a prescribing decision based on your history, and fulfillment through a licensed pharmacy — for either FDA-approved Zepbound®/Mounjaro® or compounded tirzepatide prepared under §503A. No video visit is required by state rule, and a seller offering tirzepatide without a prescription or a named pharmacy isn't a cheaper option — it's outside the system that makes any of this safe to trust. Learn more about GLP-1 treatment at Pallas or start with the New York state page for current specifics.